Current relevance of fungal and trypanosomatid glycolipids and sphingolipids: Studies defining structures conspicuously absent in mammals

Anais da Academia Brasileira de Ciencias

Volumn 81, Issue 3, 2009, Pages 477-488

  Takahashi, Helio K ^a   Toledo, Marcos S ^a   Suzuki, Erika ^b   Tagliari, Loriane ^a   Straus, Anita H ^a  

^a Setor de Imunoquímica de Glicoconjugados   (Brazil)

^b Imunologia e Parasitologia   (Brazil)

Author keywords

Glycosphingolipids; Glycosylinositol phosphorylceramides; Inositol phosphorylceramide; Leishmania; Membrane rafts; Pathogenic fungi

Indexed keywords

FUNGI; MAMMALIA; TRYPANOSOMATIDAE;

EID: 70349484417     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/s0001-37652009000300012     Document Type: Review

References (76)

1. AOKI K, UCHIYAMA R, ITONORI S, SUGITA S, CHE FS, ISOGAI A, HADA N, TAKEDA T, KUMAGAI H AND YAMAMOTO K. 2004. Structural elucidation of novel phosphocholine-containing glycosylinositol-phos-phoceramide in filamentous fungi and their induction of cell death of cultured rice cells. Biochem J 378: 461-472.
2. BARR K, AND LESTER RL. 1984. Occurrence of novel antigenic phosphoinositol-containing sphingolipids in the pathogenic yeast Histoplasma capsulatum. Biochemistry 23: 5581-5588.
3. BARR K, LAINE RA AND LESTER RL. 1984. Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. Biochemistry 23: 5589-5596.
4. BELANGER PH, JOHNSTON DA, FRATTI RA, ZHANG M AND FILLER SG. 2002. Endocytosis of Candida albicans by vascular endothelial cells is associated with tyrosine phosphorylation of specific host cell proteins. Cell Microbiol 4: 805-812.
5. BENNION B, PARK C, FULLER M, LINDSEY R, MOMANY M, JENNEMANN R AND LEVERY SB. 2003. Glycosphingolipids of the model fungus Aspergillus nidulans: Characterization of GIPCs with oligo-α-mannose-type glycans. J Lipid Res 44: 2073-2088.
6. BERTINI S, TAKAHASHI HK AND STRAUS AH. 2003. Inhibition of trypomastigotes infectivity by monoclonal antibody BST-1, directed to epimastigotes GIPCs. Crossreactivity with high molecular weight antigen present in trypomastigotes. Rev Inst Med Trop S Paulo 45: 83.
7. BERTINI S, COLOMBO AL, TAKAHASHI HK AND STRAUS AH. 2007. Expression of antibodies directed to Paracoccidioides brasiliensis glycosphingolipids during the course of paracoccidioidomycosis treatment. Clin Vaccine Immunol 14: 150-156.
8. CARDOSO DBS, ANGLUSTER J, TRAVASSOS LR AND ALVIANO CS. 1987. Isolation and characterization of a glucocerebroside (monoglucosylceramide) from Sporothrix schenckii. FEMS Microbiol Lett 43: 279-282.
9. DESCOTEAUX A AND TURCO SJ. 1999. Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta 1455: 341-352.
10. DICKSON RC AND LESTER RL. 2002. Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta 1583: 13-25.
11. DIETRICH CP. 1984. A model for cell-cell recognition and control of cell growth mediated by sulfated glycosaminoglycans. Braz J Med Biol Res 17: 5-15.
12. DIETRICH CP, SAMPAIO LO, TOLEDO OMS AND CÁSSARO CMF. 1977. Cell recognition and adhesiveness. A possible biological role for the sulfated mucopolysac-charides. Biochem Biophys Res Commun 75: 329-336.
13. DIETRICH CP, NADER HB AND STRAUS AH. 1983. Structural differences of heparan sulfates according to the tissue and species of origin. Biochem Biophys Res Commun 111: 865-871.
14. FILLER SG AND SHEPPARD DC. 2006. Fungal invasion of normallynon-phagocytichostcells. PLoSPathog2: e129.
15. GEORGOPAPADAKOU NH. 2000. Antifungals targeted to sphingolipid synthesis: Focus on inositol phosphorylceramide synthase. Expert Opin Investig Drugs 9: 1787-1796.
16. GIORGIO S, JASIULIONIS MG, STRAUS AH, TAKAHASHI HK AND BARBIERI CL. 1992. Inhibition of mouse lym-phocyteproliferativeresponsebyglycosphingolipidsfrom Leishmania(L.)amazonensis. ExpParasitol75: 119-125.
17. GIORGIO S, SANTOS MR, STRAUS AH, TAKAHASHI HK AND BARBIERI CL. 2003. Effect of glycosphi-ngolipids purified from Leishmania (Leishmania) amazo-nensis amastigotes on human peripheral lymphocytes. Clin Diagn Lab Immunol 10: 469-472.
18. GOLGHER DB, COLLI W, SOUTO-PADRÓN T AND ZIN-GALES B. 1993. Galactofuranose-containing glycocon-jugates of epimastigote and trypomastigote forms of Try-panosoma cruzi. Mol Biochem Parasitol 60: 249-264.
19. GUHA-NIYOGI A, SULLIVAN DR AND TURCO SJ. 2001. Glycoconjugate structures of parasitic protozoa. Glycobiology 11: 45-59.
20. HAKOMORI S. 2000. Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J 17: 143-151.
21. HANDMAN E. 1999. Cell biology of Leishmania. Adv Parasitol 44: 1-39.
22. HASELEY SR, VERMEER HJ, KAMERLING JP AND VLIE-GENTHART JF. 2001. Carbohydrate self-recognition me-diates marine sponge cellular adhesion. Proc Natl Acad Sci USA 98: 9419-9424.
23. HASHIDA-OKADO T, OGAWA A, ENDO M, YASUMOTO R, TAKESAKO K AND KATO I. 1996. AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells. Mol Gen Genet 251: 236-244.
24. HASHIDA-OKADO T, YASUMOTO R, ENDO M, TAKESAKO K AND KATO I. 1998. Isolation and characterization of the aureobasidin A-resistant gene, aur1R, on Schizosac-charomyces pombe: roles of Aur1p+ in cell morphogenesis. Curr Genet 33: 38-45.
25. HEIDLER SA AND RADDING JA. 1995. The AUR1 gene in Saccharomyces cerevisiae encodes a dominant resistance to the antifungal agent Aureobasidin A (LY295337). Antimicrob Agents Chemother 39: 2765-2769.
26. HEIDLER SA AND RADDING JA. 2000. Inositol phosphoryl transferases from human pathogenic fungi. Biochim Biophys Acta 1500: 147-152.
27. HEISE N, GUTIERREZ ALS, MATTOS KA, JONES C, WAIT R, PREVIATO JO AND MENDONÇA-PREVIATO L. 2002. Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans: Structural differences between encapsulated and acapsular yeast forms. Glycobiology 12: 409-420.
28. KANESHIRO ES, JAYASIMHULU K AND LESTER RL. 1986. Characterization of inositol lipids from Leishmania donovani promastigotes: identification of an inositol sphingophospholipid. J Lipid Res 27: 1294-1303.
29. KOJIMA N AND HAKOMORI S. 1991. Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. J Biol Chem 266: 17552-17558.
30. KURODA M, HASHIDA-OKADO T, YASUMOTO R, GOMI K, KATO I AND TAKESAKO K. 1999. An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity. Mol Gen Genet 261: 290-296.
31. LEIPELT M, WARNECKE D, ZAHRINGER U, OTT C, MUL-LER F, HUBE B AND HEINZ E. 2001. Glucosylceramide synthases, a gene family responsible for the biosynthesis of glucosphingolipids in animals, plants, and fungi. J Biol Chem 276: 33621-33629.
32. LEVERY SB, TOLEDO MS, STRAUS AH AND TAKAHASHI HK. 1998. Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: An immunodominant β-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen. Biochemistry 37: 8764-8775.
33. + adduct ions. Rapid Commun Mass Spectrom 14: 551-563.
34. LEVERY SB, MOMANY M, LINDSEY R, TOLEDO MS, SHAYMAN JA, FULLER M, BROOKS K, DOONG RL, STRAUS AH AND TAKAHASHI HK. 2002. Disruption of the glucosylceramide biosynthesis pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc: ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth. FEBS Lett 525: 59-64.
35. LOUREIRO Y, PENHA CV, TODESCHINI AR, LOPES-BEZERRA LM, WAIT R, JONES C, MATTOS KA, HEISE N, MENDONÇA-PREVIATO L AND PREVIATO JO. 2001. Characterization of novel structures of mannosylinositol phosphorylceramides from the yeast forms of Sporothrix schenckii. Eur J Biochem 268: 4243-4250.
36. MANDALA SM, THORNTON RA, ROSENBACH M, MILLIGAN J, GARCIA-CALVO M, BULL HG AND KURTZ MB. 1997. Khafrefungin, a novel inhibitor of sphingolipid synthesis. J Biol Chem 272: 32709-32714.
37. MANDALA SM ET AL. 1998. Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at the inositol phosphoceramide synthase. J Biol Chem 273: 14942-14949.
38. MAÑES S, DEL REAL G AND MARTÍNEZ-A C. 2003. Pathogens: raft hijackers. Nat Rev Immunol 3: 557-568.
39. MATSUURA K AND KOBAYASHI K. 2004. Analysis of GM3Gg3 interaction using clustered gycoconjugate models constructed from glycolipid monolayers and artificial glycoconjugate polymers. Glycoconj J 21: 139-148.
40. MAZA PK, STRAUS AH, TOLEDO MS, TAKAHASHI HK AND SUZUKI E. 2008. Interaction of epithelial cell membrane rafts with Paracoccidioides brasiliensis leads to fungal adhesion and Src-family kinase activation. Microbes Infect 10: 540-547.
41. MCCONVILLE MJ AND BACIC A. 1989. A family of glycoinositol phospholipids from Leishmania major, Isolation, characterization, and antigenicity. J Biol Chem 264: 757-766.
42. MENDES-GIANNINI MJ, SOARES CP, DA SILVA JL AND ANDREOTTI PF. 2005 Interaction of pathogenic fungi withhostcells: Molecularandcellularapproaches. FEMS Immunol Med Microbiol 45: 383-394.
43. MONTEIRO DA SILVA JL, ANDREOTTI PF, BENARD G, SOARES CP, MIRANDA ET AND MENDES-GIANNINI MJ. 2007. Epithelial cells treated with genistein inhibit adhesion and endocytosis of Paracoccidioides brasiliensis. Antonie Van Leeuwenhoek 92: 129-135.
44. MOORE CB, SAYERS N, MOSQUERA J, SLAVEN J AND DENNING DW. 2000. Antifungal drug resistance in Aspergillus. J Infect 41: 203-220.
45. NAGIEC MM, NAGIEC EE, BALTISBERGER JA, WELLS GB, LESTER RL AND DICKSON RC. 1997. Sphingo-lipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem 272: 9809-9817.
46. NETEA MG, BROWN GD, KULLBERG BJ AND GOW NA. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67-78.
47. NOGUEIRA NFS, GONZALEZ MS, GOMES JE, SOUZA W, GARCIA ES, AZAMBUJA P, NOHARA LL, ALMEIDA IC, ZINGALES B AND COLLI W. 2007. Trypanosoma cruzi: Involvement of glycoinositolphospholipids in the attachment to the luminal midgut surface of Rhodnius prolixus. Exp Parasitol 116: 120-128.
48. ODDS FC, BROWN AJP AND GOW NAR. 2003. Antifungal agents: mechanismsofaction. TrendsMicrobiol11: 272-279.
49. PIKE LJ. 2003. Lipid rafts: bringing order to chaos. J Lipid Res 44: 655-667.
50. PIKE LJ. 2006. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47: 1597-1598.
51. RADIN NS, SHAYMAN JA AND INOKUCHI J. 1993. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv Lipid Res 26: 183-213.
52. RAJENDRAN L AND SIMONS K. 2005. Lipid rafts and membrane dynamics. J Cell Sci 118: 1099-1102.
53. RITTIG MG AND BOGDAN C. 2000. Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 16: 292-297.
54. SAITO K, TAKAKUWA N, OHNISHI M AND ODA Y. 2006. Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast. Appl Microbiol Biotechnol 71: 515-521.
55. SILVEIRA TGV, YONEYAMA KAG, TAKAHASHI HK AND STRAUS AH. 2005. Isolation of Leishmania (Viannia) braziliensis glycolipid antigens and their reactivity with mAb SST-1, specific for parasites of Viannia subgenus. Parasitology 131: 737-745.
56. SIMENEL C, CODDEVILLE B, DELEPIERRE M, LATGÉ JP AND FONTAINE T. 2008. Glycosylinositolphosphoceramides in Aspergillus fumigatus. Glycobiology 18: 84-96.
57. SPATH GF, GARRAWAY LA, TURCO SJ AND BEVERLEY SM. 2003. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci USA 100: 9536-9541.
58. STEINER S, SMITH S, WAECHTER CJ AND LESTER RL. 1969. Isolation and partial characterization of a major inositol-containing lipid in Baker's yeast, mannosyl-diinositol, di-phosphoryl-ceramide. Proc Natl Acad Sci USA 64: 1042-1048.
59. STRAUS AH, LEVERY SB, JASIULIONIS MG, SALYAN ME, STEELE SJ, TRAVASSOS LR, HAKOMOR IS AND TAKA-HASHI HK. 1993. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. J Biol Chem 268: 13723-13730.
60. STRAUS AH, VALERO VB, TAKIZAWA CM, LEVERY SB, TOLEDO MS, SUZUKI E, SALYAN ME, HAKOMORI S, BARBIERI CL AND TAKAHASHI HK. 1997. Glycosphin-golipid antigens from Leishmania (L.) amazonensis amas-tigotes. Binding of anti-glycosphingolipid monoclonal antibodies in vitro and in vivo. Braz J Med Biol Res 30: 395-399.
61. SUZUKI E, TOLEDO MS, TAKAHASHI HK AND STRAUS AH. 1997. A monoclonal antibody directed to terminal residue of β-galactofuranose of a glycolipid antigen isolated from Paracoccidioides brasiliensis: cross-reactivity with Leishmania major and Trypanosoma cruzi. Glycobiology 7: 463-468.
62. SUZUKI E, TANAKA AK, TOLEDO MS, TAKAHASHI HK AND STRAUS AH. 2002. Role of β-d-galactofuranose in Leishmania major macrophage invasion. Infect Immun 70: 6592-6596.
63. SUZUKI E, TANAKA AK, TOLEDO MS, LEVERY SB, TAKAHASHI HK AND STRAUS AH. 2008. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new thera-peutic strategies. Biochim Biophys Acta 1780: 362-369.
64. TAKESAKO K, KURODA H, INOUE T, HARUNA F, YOSHI-KAWA Y AND KATO I. 1993. Biological properties of Aureobasidin A, a cyclic depsipeptide antifungal antibio-tic. J Antibiot 49: 1414-1420.
65. TANAKA AK, GORIN PAJ, TAKAHASHI HK AND STRAUS AH. 2007. Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity. Braz J Med Biol Res 40: 799-806.
66. TOLEDO MS, SUZUKI E, STRAUS AH AND TAKAHASHI HK. 1995. Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. J Med Vet Mycol 33: 247-251.
67. TOLEDO MS, LEVERY SB, STRAUS AH, SUZUKI E, MO-MANY M, GLUSHKA J, MOULTON JM AND TAKAHASHI HK. 1999. Characterization of sphingolipids from mycopathogens: Factors correlating with expression of 2hydroxy fatty acyl (E)-13-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. Biochemistry 38: 7294 7306.
68. TOLEDO MS, LEVERY SB, STRAUS AH AND TAKAHASHI HK. 2000. Dimorphic expression of cerebrosides in the mycopathogen Sporothrix schenckii. J Lipid Res 41: 797-806.
69. TOLEDO MS, LEVERY SB, STRAUS AH AND TAKAHASHI HK. 2001a. Sphingolipids of the mycopathogen Sporothrix schenckii: Identification of a glycosylinositol phosphorylceramide novel core GlcNH2α1→2Ins motif. FEBS Lett 493: 50-56.
70. TOLEDO MS, LEVERY SB, GLUSHKA J, STRAUS AH AND TAKAHASHI HK. 2001b. Structure elucidation of sphingolipids from the mycopathogen Sporothrix schenckii: Identification of novel glycosylinositol phosphorylceramides with core Manα1→6Ins linkage. Biochem Biophys Res Commun 280: 19-24.
71. TOLEDO MS, LEVERY SB, SUZUKI E, STRAUS AH AND TAKAHASHI HK. 2001c. Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum: expression of 2-hydroxy fatty Nacyl (E)-Delta(3)-unsaturation correlates with the yeastmycelium phase transition. Glycobiology 11: 113-124.
72. TOLEDO MS, LEVERY SB, BENNION B, GUIMARÃES LL, CASTLE SA, LINDSEY R, MOMANY M, PARK C, STRAUS AH AND TAKAHASHI HK. 2007. Analysis of glycosylinositol phosphorylceramides expressed by the opportunistic mycopathogen Aspergillus fumigatus. J Lipid Res 48: 1801-1824.
73. TOLMASKY ME, TAKAHASHI HK, STANELONI RJ AND LELOIR LF. 1982. N-glycosylation of proteins in plants. An Asoc Quim Argent 70: 405-411.
74. ′-hydroxyoctadecenoyl-1-O-beta-D-glucopyranosyl-9met hyl-4,8-sphingadienine from species of Aspergillus. Chem Phys Lipids 70: 11-19.
75. YONEYAMA KAG, TANAKA AK, SILVEIRA TGV, TAKAHASHI HK AND STRAUS AH. 2006. Characterization of Leishmania (Viannia) braziliensis membrane microdomains, and their role in macrophage infectivity. J Lipid Res 47: 2171-2178.
76. ZAJCHOWSKI LD AND ROBBINS SM. 2002. Lipid rafts and little caves. Compartmentalized signaling in membrane microdomains. Eur J Biochem 269: 737-752.